Journal of Turkish Society for Rheumatology (formerly RAED Journal), the official publication of the Turkish Society for Rheumatology, is an international, open access, scientific, peer-reviewed journal that adheres to the principles of independent, unbiased, and double-blind peer review.
The journal is published tri-annually (March, July and November) in Turkish and English, in electronic format (p-ISSN: 2651-2653).
The journal publishes original contributions in the field of rheumatology, including experimental and clinical research articles, review articles, case reports, letters to the editor, and scientific communications. In addition, abstracts or full texts of scientific meetings related to rheumatology may be published as supplementary issues.
Journal of Turkish Society for Rheumatology aims to constitute a current scientific discussion platform and archive in rheumatology with the contribution of the disciplines related to rheumatology together. The journal intends to share its experiences with the international scientific community in a prestigious way and provide an academic contribution to the development of rheumatology science.
The abbreviation of the Journal of Turkish Society for Rheumatology is “J Turk Soc Rheumatol”.
The article types in the journal are classified as below:
- Clinical Research Article
- Experimental Study
- Case Report
- Review
- Letter to the Editor
- Recommendation
- Letter to the Author
- Book Review
- News
- Abstracts
The editorial and publication process of the Journal of the Journal of Turkish Society for Rheumatology are shaped in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics (COPE), European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal is in conformity with the Principles of Transparency and Best Practice in Scholarly Publishing.
All submissions must be accompanied by a signed statement of scientific contributions and responsibilities of all authors and a statement declaring the absence of conflict of interests. Any institution, organization, pharmaceutical or medical company providing any financial or material support, in whole or in part, must be disclosed in a footnote (ICMJE Disclosure Form for Potential Conflict of Interest(s)).
The manuscript format must comply with the ICMJE-Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (updated in December 2018).
The presentation of the article types must be designed in accordance with trial reporting guidelines:
Human research: Helsinki Declaration as revised in 2024
Systematic reviews and meta-analyses: PRISMA guidelines
Case reports: the CARE case report guidelines
Clinical trials: CONSORT
Animal studies: ARRIVE and Guide for the Care and Use of Laboratory Animals
Clinical Trial Policy
All clinical trials, which are any research projects that prospectively assign individuals or a group of people to an intervention, with or without concurrent comparison or control groups, in order to study the relationship between a health-related intervention and a health outcome, must be registered in a public trials registry acceptable to the International Committee of Medical Journals Editors (ICMJE). Authors of randomized controlled trials must adhere to the CONSORT guidelines , and provide both a CONSORT checklist (for protocols, see the SPIRIT guidance) and flow diagram. We require that you choose the MS Word template at www.consort-statement.org for the flow chart and cite/upload it in the manuscript as a figure. In addition, submitted manuscripts must include the unique registration number in the Abstract as evidence of registration. The Clinical Trial Registration Policy has been implemented in our journal as of September 2023.
You can register for clinical trials by visiting the following link:
To register the relevant record in the system and learn more about the protocol to be followed, please review the link below:
https://classic.clinicaltrials.gov/ct2/manage-recs/how-register
The other registries are accepted by ICJME:
Use of Large Language Models and Generative AI Tools
“AI tools cannot meet the requirements for authorship as they cannot take responsibility for the submitted work. As non-legal entities, they cannot assert the presence or absence of conflicts of interest nor manage copyright and license agreements. Authors who use AI tools in the writing of a manuscript, production of images or graphical elements of the paper, or in the collection and analysis of data, must be transparent how the AI tool was used and which tool was used. Authors are fully responsible for the content of their manuscript, even those parts produced by an AI tool, and are thus liable for any breach of publication ethics.” COPE Position Statement on Authorship and AI tools. Detailed information about the statement can be accessed at https://publicationethics.org/cope-position-statements/ai-author
After reviewing the COPE statement, the editors of the Journal of Turkish Society for Rheumatology have decided that papers should include a statement in a section called “Declaration Regarding the Use of AI and AI-Assisted Technologies” to let readers know if AI or AI-assisted tools were used in the writing process. It's important to remember that all authors are responsible for the content of their work. This declaration does not apply to the use of basic tools for checking grammar, spelling, or references (such as Mendeley, EndNote, Zotero, and others). If there is nothing to declare, there is no need to add a statement.
It is suggested that authors follow this format when preparing their statement:
During the preparation of this work, the author(s) utilized [NAME OF TOOL(S) USED] to [DESCRIPTION OF HOW THE TOOL(S) WERE UTILIZED AND HOW THE VALIDITY OF THE OUTPUTS WAS EVALUATED]. After carefully reviewing and editing the content as necessary, full responsibility for the publication's content is taken by the author(s). This incorporation of AI tool usage primarily impacted [SPECIFY WHICH ASPECTS OF THE STUDY, ARTICLE CONTENTS, DATA, OR SUPPORTING FILES WERE AFFECTED/GENERATED].
Example:
During the preparation of this work, the author(s) utilized OpenAI's ChatGPT to generate summaries of research articles related to the topic. These summaries were evaluated by comparing them to manually written summaries by experts in the field. Upon confirming the accuracy and relevance of the generated summaries, they were integrated into the literature review section of the manuscript. After carefully reviewing and editing the content as necessary, full responsibility for the publication's content is taken by the author(s). This incorporation of AI tool usage primarily impacted the efficiency of literature review process and the comprehensiveness of the gathered research insights.
GENERAL RULES
Apart from the features mentioned below, the "International Committee of Medical Journal Editors (ICMJE). Uniform Requirements for Manuscripts" documents (www.icmje.org) should be taken as a basis.
The sections that should be included in the articles to be sent to the journal are as follows and should be presented in a way that each starts on a separate page:
Page 1: Title page
Page 2: Turkish Title, Abstract and Keywords
Page 3: Title, Abstract and Key Words in English
Page 4 and afterwards: Main Text
Next page: Resources
Next page: Table Explanation and Table (each table should be specified on a separate page)
Next page: Figure and Image Subtitles and Image / Shapes (each shape must be specified on a separate page)
Title Page
The title page should be considered in the following order:
1- The category in which the article was sent (clinical research, experimental study, review, case report, etc.)
2- Title of the article (the title should not exceed 80 characters and should not contain non-standard abbreviations)
3- Name, surname, contact addresses of the authors and the institution they work at the time of the research
4- The abbreviated title of the article, which is desired to appear at the top of the continuation pages when published in the journal and does not exceed 40 characters.
5- Supporting institutions and organizations, if any.
6- If the article has been submitted before, details of the meeting it was presented
7- Communication information of the author to be contacted
8- If any, indicating the financial support regarding the content of the article.
Turkish Abstract
The research articles should consist of the Objectives, Methods, Results and Conclusion sections and should not exceed 250 words. An unstructured abstract should be provided in reviews and case reports. The abstract of case reports should not exceed 100 words. A minimum of 3 and a maximum of 6 keywords should be specified on the Turkish abstract page.
English Abstract
The research articles should consist of Objectives, Methods, Results and Conclusion sections and should not exceed 250 words. At least 3, a maximum of 6 English keywords should be determined on the English Abstract page, and the English title of the article should be added.
Main Text
The introduction should consist of the Patients / Materials and Methods, Results, Discussion and References sections. Abbreviations should be standard and should be explained in parentheses when they are used first. Internationally accepted units should be used in the measurements.
Tables, Figures and Images
It should be numbered in the order of use in the text, and unnecessary use should be avoided. In the photographs used in the cases, permission should be obtained, and necessary measures should be applied to prevent recognition. Attention should be paid to the quality of photographs and drawings, if any. Editorial Board may request correction or renewal in tables, figures and pictures on the grounds that it is not of sufficient quality. Figures and pictures must be original. For the pictures, figures and graphics used in another publication to be published in our journal, the necessary permissions must be obtained by the authors and before applying for an article. A copy of the document indicating that the permit has been obtained must be sent to the journal with the article.
References
References should be selected from the ones that are up to date and necessary for the article. References in the text should be indicated in parentheses and numbered according to the order of use. The name of the journals should be abbreviated in accordance with PubMed rules, and abbreviations should not be used in the names of journals which are not included here. Citation of proceedings should be avoided. Manuscripts accepted by a journal but not yet published can be documented as required and used as a source. Information other than this, including unaccepted articles, can be used by stating "unpublished observation" in the article. References should be written according to the examples below, and all the authors should be presented in references up to 6 authors, references which have more authors should be arranged in a way that "et al." abbreviation will be placed at the end of the first three authors. The responsibility for the accuracy of the references belongs to the authors.
Examples:
Periodical publication example in Turkish:
Göksedef D, Ömeroğlu NÖ, Denli Ş, Üreyen C, Sayılgan C, İpek G. Sistemik lupus eritematozuslu bir olguda aort yetmezliği nedeniyle aort kapak replasmanı. Cerrahpaşa Tıp Dergisi. 2008;39:73-5.
Periodical publication example in a foreign language:
Wolfe F, Hawley DJ, Cathey MA. Termination of slow-acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol. 1990;17:994-1002.
Example of periodical publication published in an online journal:
Yurdakul S. Is there a higher risk of infection with anti-TNF-alpha agents, or is there a selection bias? Lett Ed Rheumatol. 1(1):e110006. doi:10.2399/ler.11.0006
Example of book section:
Buchanan WW, Dequeker J. History of rheumatic diseases. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. Edinburgh: Mosby; 2003:3-
It is recommended that the prepared articles are reviewed according to the following checklist before being sent to the journal:
1- Title page
2- Abstracts (Turkish and English; maximum 100 words in case reports, maximum 250 words in others; structured in research papers)
3- Keywords (at least three each)
4- Main text (subheadings)
5- Resources (Compliance with ICMJE rules)
6- Figures, tables and pictures (numbering; subtitles; originality/permission letter)
7- Application letter
8- Copyright Agreement Form (signed by all authors)
9- Conflict of Interest Declaration Form (if required)
